Expression of breast cancer resistance protein in blast cells from patients with acute leukemia

Blood

Volumn 96, Issue 1, 2000, Pages 365-368

  Ross, Douglas D ^a   Karp, Judith E ^b   Chen, Tar T ^b   Doyle, L Austin ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; TOPOTECAN;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; BREAST CANCER; CANCER REGRESSION; CANCER RESISTANCE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034234653     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.365.013k46_365_368     Document Type: Article

References (14)

1. Karp JE. Acute leukemia: mechanisms of cell survival as targets for therapy [review], Int J Oncol. 1997;11:657.
2. Ross DD. Novel mechanisms of drug resistance in acute leukemia. Leukemia. 2000;14:467.
3. Leith CP, Kopecky KJ, Chen I-M, et al. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group study. Blood. 1999; 94:1086.
4. Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA. 1998;95: 15665.
5. Miyake K, Mickley L, Litman T, et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 1999;59:8.
6. Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 1998;58:5337.
7. Ross DD, Yang W, Abruzzo LV, et al. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst. 1999; 91:429.
8. Maliepaard M, VanGastelen MA, DeJong LA, et al. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 1999;59:4559.
9. Ross DD, Doyle LA, Schiffer CA, et al. Expression of multidrug resistance-associated protein (MRP) mRNA transcripts in blast cells from acute myeloid leukemia (AML) patients. Leukemia. 1996;10:48.
10. Bloomfield CD, Lawrence D, Byrd JC, et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute leukemia varies by cytogenetic subtype. Cancer Res. 1998;58:4173.
11. Bloomfield CD, Shuma C, Regal L, et al. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer. 1997;80:2191.
12. Weinstein JN, Myers TG, O'Connor PM, et al. An information-intensive approach to the molecular pharmacology of cancer. Science. 1997;275:343.
13. List AF, Spier C, Greer J, et al. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol. 1993;11: 1652.
14. Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res. 2000;60:47.